Suppr超能文献

通过支气管肺泡灌洗诊断免疫功能正常宿主的肺毛霉菌病。

Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage.

作者信息

Kumar Sunil, Joshi Divya

机构信息

Pathology, KS Hegde Medical Academy, Mangalore, India.

Pathology, KS Hegde Medical Academy, Mangalore, India

出版信息

BMJ Case Rep. 2021 Apr 12;14(4):e240180. doi: 10.1136/bcr-2020-240180.

Abstract

Mucormycosis is a rare infection caused by Mucorales fungi belonging to Zygomycetes class. It can present with spectrum of symptoms and signs based of organ involvement. Common forms of mucormycosis includes rhinocerebral, cutaneous, gastrointestinal, pulmonary, disseminated and miscellaneous forms involving bones, breast, kidney and central nervous system. Pulmonary mucormycosis usually present with fever, cough, haemoptysis and is usually seen in immunocompromised patients like patients with diabetes or leukaemia, or those on chemotherapy or immunosuppressive therapy and rare in immunocompetent patients (6.25% of cases). Pulmonary mucormycosis can be diagnosed by radiological imaging studies, bronchoalveolar lavage (BAL) and histopathological evaluation of biopsy of the lesion; however, the gold standard is a positive fungal culture. Here, we describe two cases of pulmonary mucormycosis diagnosed by BAL in an immunocompetent patient.

摘要

毛霉病是一种由属于接合菌纲的毛霉目真菌引起的罕见感染。它可根据受累器官出现一系列症状和体征。毛霉病的常见形式包括鼻脑型、皮肤型、胃肠道型、肺型、播散型以及累及骨骼、乳腺、肾脏和中枢神经系统的其他类型。肺毛霉病通常表现为发热、咳嗽、咯血,常见于免疫功能低下的患者,如糖尿病或白血病患者,或接受化疗或免疫抑制治疗的患者,在免疫功能正常的患者中较为罕见(占病例的6.25%)。肺毛霉病可通过放射影像学检查、支气管肺泡灌洗(BAL)和病变活检的组织病理学评估来诊断;然而,金标准是真菌培养阳性。在此,我们描述了两例在免疫功能正常的患者中通过BAL诊断为肺毛霉病的病例。

相似文献

1
Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage.
BMJ Case Rep. 2021 Apr 12;14(4):e240180. doi: 10.1136/bcr-2020-240180.
2
[Primary cutaneous mucormycosis: two case reports and review of the literature].
Rev Chilena Infectol. 2011 Jun;28(3):269-73. Epub 2011 Jul 14.
3
The role of BAL in the diagnosis of pulmonary mucormycosis.
Chest. 2000 Jan;117(1):279-82. doi: 10.1378/chest.117.1.279.
4
Fatal renal mucormycosis with in an apparently healthy male.
Aging Male. 2020 Dec;23(5):746-749. doi: 10.1080/13685538.2019.1586871. Epub 2019 Mar 16.
5
Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis.
J Clin Microbiol. 2018 Jul 26;56(8). doi: 10.1128/JCM.00289-18. Print 2018 Aug.
6
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Ann Pharmacother. 2016 Sep;50(9):747-57. doi: 10.1177/1060028016655425. Epub 2016 Jun 15.
7
Disseminated infection due to Saksenaea vasiformis secondary to cutaneous mucormycosis.
Mycopathologia. 2014 Feb;177(1-2):97-101. doi: 10.1007/s11046-013-9715-3. Epub 2013 Nov 1.
8
Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia.
BMC Pulm Med. 2017 Apr 28;17(1):76. doi: 10.1186/s12890-017-0419-1.
9
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7.
10
[Pulmonary mucormycosis: difficulties in diagnosis and treatment].
Rev Mal Respir. 2007 May;24(5):617-21. doi: 10.1016/s0761-8425(07)91129-8.

引用本文的文献

1
Aggressive Management of Pulmonary Mucormycosis Necrotizing Fasciitis in a Post-Liver Transplant Patient.
Cureus. 2025 Feb 6;17(2):e78649. doi: 10.7759/cureus.78649. eCollection 2025 Feb.
2
Pulmonary mucormycosis in an immunocompetent young female: a case report and literature review.
Front Med (Lausanne). 2024 Dec 24;11:1491489. doi: 10.3389/fmed.2024.1491489. eCollection 2024.
3
Pulmonary Mucormycosis in an Older Acute Myeloid Leukemia Patient.
J Med Cases. 2025 Jan;16(1):23-27. doi: 10.14740/jmc5042. Epub 2024 Nov 23.
4
Fatal Tracheal and Bronchial Destruction Due to Pulmonary Mucormycosis in a 20-Year-Old with Diabetic Ketoacidosis.
Infect Drug Resist. 2024 Dec 6;17:5429-5437. doi: 10.2147/IDR.S493002. eCollection 2024.
5
A rare case of pulmonary mucormycosis and broncho-esophageal fistula in a patient with poorly controlled diabetes.
Clin Case Rep. 2024 Jun 28;12(7):e9093. doi: 10.1002/ccr3.9093. eCollection 2024 Jul.

本文引用的文献

1
Disease Entities in Mucormycosis.
J Fungi (Basel). 2019 Mar 14;5(1):23. doi: 10.3390/jof5010023.
2
Pulmonary mucormycosis in an adolescent female with type 1 diabetes mellitus.
IDCases. 2018 Nov 27;14:e00474. doi: 10.1016/j.idcr.2018.e00474. eCollection 2018.
3
Pulmonary mucormycosis mimicking an endobronchial mass.
Asian Cardiovasc Thorac Ann. 2018 Mar;26(3):242-244. doi: 10.1177/0218492318760711. Epub 2018 Feb 15.
4
Diagnosis and treatment of pulmonary mucormycosis: A case report.
Exp Ther Med. 2017 Oct;14(4):3788-3791. doi: 10.3892/etm.2017.4986. Epub 2017 Aug 22.
5
Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings.
Eur Radiol. 2018 Feb;28(2):788-795. doi: 10.1007/s00330-017-5007-5. Epub 2017 Aug 10.
6
Pulmonary mucormycosis mimicking as pulmonary tuberculosis: a case report.
Lung India. 2008 Jul;25(3):129-31. doi: 10.4103/0970-2113.59595.
7
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Clin Infect Dis. 2005 Sep 1;41(5):634-53. doi: 10.1086/432579. Epub 2005 Jul 29.
8
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
Clin Microbiol Rev. 2005 Jul;18(3):556-69. doi: 10.1128/CMR.18.3.556-569.2005.
9
Pulmonary mucormycosis diagnosed by fine needle aspiration cytology. A case report.
Acta Cytol. 2001 May-Jun;45(3):411-4. doi: 10.1159/000327640.
10
The role of BAL in the diagnosis of pulmonary mucormycosis.
Chest. 2000 Jan;117(1):279-82. doi: 10.1378/chest.117.1.279.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验